Cite
HARVARD Citation
Cognetti, D. et al. (2021). Phase 1/2a, open‐label, multicenter study of RM‐1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma. Head & neck. 43 (12), pp. 3875-3887. [Online].